Retour
46
Fourchette du Jour
73,79 €
76,58 €
Fourchette 52 Semaines
62,77 €
93,50 €
Volume
128 303
Moyenne 50J / 200J
83,01 €
/
80,91 €
Clôture Précédente
73,86 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 75,9 | 0,4 |
| P/B | 2,4 | 2,9 |
| ROE % | 3,1 | 3,8 |
| Net Margin % | 1,9 | 3,9 |
| Rev Growth 5Y % | 12,1 | 10,0 |
| D/E | 0,9 | 0,2 |
Points Clés
Revenue grew 12,07% annually over 5 years — strong growth
Earnings declined -43,08% over the past year
ROE of 3,12% is below average
Generating 60,99M in free cash flow
P/E of 75,91 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,26%
Croissance
Revenue Growth (5Y)
12,07%
Revenue (1Y)16,33%
Earnings (1Y)-43,08%
FCF Growth (3Y)-8,40%
Qualité
Return on Equity
3,12%
ROIC6,69%
Net Margin1,93%
Op. Margin10,30%
Sécurité
Debt / Equity
0,89
Current Ratio1,01
Interest Coverage8,50
Valorisation
P/E Ratio
75,91
P/B Ratio2,40
EV/EBITDA19,07
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,33% | Revenue Growth (3Y) | 13,64% |
| Earnings Growth (1Y) | -43,08% | Earnings Growth (3Y) | 1,31% |
| Revenue Growth (5Y) | 12,07% | Earnings Growth (5Y) | -14,22% |
| Profitability | |||
| Revenue (TTM) | 780,99M | Net Income (TTM) | 15,06M |
| ROE | 3,12% | ROA | 1,25% |
| Gross Margin | 20,15% | Operating Margin | 10,30% |
| Net Margin | 1,93% | Free Cash Flow (TTM) | 60,99M |
| ROIC | 6,69% | FCF Growth (3Y) | -8,40% |
| Safety | |||
| Debt / Equity | 0,89 | Current Ratio | 1,01 |
| Interest Coverage | 8,50 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 75,91 | P/B Ratio | 2,40 |
| P/S Ratio | 1,46 | PEG Ratio | -3,45 |
| EV/EBITDA | 19,07 | Dividend Yield | 0,02% |
| Market Cap | 1,14B | Enterprise Value | 1,53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 780,99M | 671,35M | 604,80M | 553,14M | 495,02M |
| Net Income | 15,06M | 26,46M | 14,67M | 28,27M | 27,82M |
| EPS (Diluted) | 1,42 | 1,84 | 1,28 | 3,34 | 4,49 |
| Gross Profit | 157,34M | 123,92M | 121,51M | 112,02M | 117,18M |
| Operating Income | 80,43M | 63,21M | 52,06M | 56,80M | 70,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,20B | 1,17B | 997,24M | 858,15M | 749,43M |
| Total Liabilities | 433,81M | 408,42M | 345,00M | 373,59M | 296,98M |
| Shareholders' Equity | 476,43M | 488,93M | 476,19M | 315,79M | 295,61M |
| Total Debt | 425,74M | 295,23M | 258,59M | 295,34M | 223,08M |
| Cash & Equivalents | 35,57M | 41,36M | 152,83M | 31,59M | 28,57M |
| Current Assets | 139,99M | 137,58M | 233,38M | 111,27M | 95,17M |
| Current Liabilities | 139,04M | 116,28M | 102,19M | 85,49M | 83,48M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#492 of 1024
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026